Cita APA

Zaman, S., Shentu, S., Yang, J., He, J., Orlowski, R. Z., Stellrecht, C. M., & Gandhi, V. (2015). Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()(). Neoplasia.

Citación estilo Chicago

Zaman, Shadia, Shujun Shentu, Jing Yang, Jin He, Robert Z. Orlowski, Christine M. Stellrecht, y Varsha Gandhi. "Targeting the Pro-Survival Protein MET With Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()." Neoplasia 2015.

Cita MLA

Zaman, Shadia, et al. "Targeting the Pro-Survival Protein MET With Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()." Neoplasia 2015.